ABC News
•
71% Informative
Dr. Angela Fitch : "This is not for the weak-willed" Doctors and patients say getting the high-demand, injectable drugs requires persistence and luck.
Some insurers and employers don't pay for Wegovy or other weight-loss drugs.
The drug's maker, Novo Nordisk , has said it expects tight supplies until year's end for its diabetes treatment Mounjaro .
About 46% of large U.S. employers cover obesity medicines like Wegovy , according to the benefits consultant Mercer .
The FDA may soon approve Mounjaro to treat obesity, which could improve coverage.
Drugmakers also are developing other weight-loss medications, including easier-to-take pills.
VR Score
78
Informative language
83
Neutral language
36
Article tone
informal
Language
English
Language complexity
48
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links